Keith Wheatley
- Establishing the presence of the t( 15; 17) in suspected acute promyelocytic leukaemia: cytogenetic, molecular and PML immunofluorescence assessment of patients entered into the M.R.C. ATRA trial
1996/09/01 by David Grimwade, Kathy Howe, Stephen Langrbeer +8 · 2 citations
Biochemistry, Genetics and Molecular Biology · Medicine · #Childhood leukaemia #Chronic Lymphocytic Leukemia Research #Family medicine #Library science #Medicine #Pediatrics #Protein Degradation and Inhibitors #Retinoids in leukemia and cellular processes
- Longer-term efficiency and safety of increasing the frequency of whole blood donation (INTERVAL): extension study of a randomised trial of 20 757 blood donors
2019/08/02 by Stephen Kaptoge, Emanuele Di Angelantonio, Carmel Moore +88 · 1 citation
Business, Management and Accounting · Medicine · #Blood donation and transfusion practices #Organ Donation and Transplantation #Blood transfusion and management
- A simple, robust, validated and highly predictive index for the determination of risk‐directed therapy in acute myeloid leukaemia derived from the MRC AML 10 trial
1999/10/01 by Keith Wheatley, Alan K. Burnett, Anthony H. Goldstone +6 · 1 citation
Biochemistry, Genetics and Molecular Biology · Medicine · #Acute Myeloid Leukemia Research #Adverse effect #Biology #Clinical trial #Cytogenetics #Disease #Internal medicine #Medicine #Multiple Myeloma Research and Treatments #Myeloid #Myeloid leukaemia #Myeloid leukemia #Oncology #Retinoids in leukemia and cellular processes #Surgery
- Rituximab for High-Risk, Mature B-Cell Non-Hodgkin’s Lymphoma in Children
2020/06/03 by Véronique Minard‐Colin, Anne Aupérin, Marta Pillon +17 · 1 voice
Medicine · #Acute Lymphoblastic Leukemia research #CAR-T cell therapy research #Lymphoma Diagnosis and Treatment